Journal Responds to Controversy Over Embryo Gene-Editing Paper
By Jocelyn Kaiser,
Science Magazine
| 04. 28. 2015
Untitled Document
The journal that days ago published the first-ever paper on an attempt to genetically modify human embryos has come out in defense of its decision and rebuffed claims that the paper was not adequately peer reviewed.
The paper appeared online on 18 April in Protein & Cell, which is co-published by Springer and an affiliate of China’s Ministry of Education. Junjiu Huang and colleagues at Sun Yat-sen University in Guangzhou describe their efforts to use the CRISPR-Cas9 gene-editing technology to alter a gene in abnormal human embryos. Their gene-editing effort was not very successful and introduced many unintentional mutations.
The paper has touched off a furor from scientists and others who have called for a moratorium on any efforts to establish a pregnancy with such a genetically modified embryo. Many have deemed Huang’s experiment unethical, and Huang himself has reportedly said that the paper was rejected by Science and Nature in part for ethical reasons.
This week, Protein & Cell defended its decision to publish the paper. An editorial posted online on 28 April says the journal’s...
Related Articles
GeneWatch UK has prepared a briefing on the genetic modification of nature for the International Union for Conservation of Nature (IUCN) Congress in October 2025
The upcoming Congress claims to be “where the world comes together to set priorities and drive conservation and sustainable development action.” A major concern for those on the outside is that the Congress may advance plans to develop and encourage the use of synthetic biology in nature conservation. This could at first glance sound like...
By Aaron Ginn, The Washington Post | 09.12.2025
Earlier this year, I had dinner in D.C. with Jensen Huang, the president and chief executive of Nvidia. At one point, he said something that struck me: “Why is everyone here so negative?”
He wasn’t referring to the economy...
By Roni Caryn Rabin, The New York Times | 08.25.2025
Scientists have dreamed for centuries about using animal organs to treat ailing humans. In recent years, those efforts have begun to bear fruit: Researchers have begun transplanting the hearts and kidneys of genetically modified pigs into patients, with varying degrees...
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...
